Clinical Trial Update: A Study Of New Medicine (GSK 372475) For The Treatment Of Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for GlaxoSmithKline's GSK 372475 in depressive disorder; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder

Drugs mentioned

• GSK 372475 (GSK 372475)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder | Phase 2 | Status: COMPLETED